Tattoo removal: FDA clears Cynosure's 532 nm laser system

The FDA clears Cynosure's 532 nm Laser Delivery System for its PicoSure tattoo-removal technology platform.

The FDA has cleared Cynosure's (NSDQ:CYNO) 532 nm Laser Delivery System for its PicoSure tattoo-removal technology platform.

Cynosure said the regulatory win will enable the PicoSure system to remove all colors of ink in fewer sessions.

Cynosure Inc., Food & Drug Administration (FDA)

News Well, Regulatory

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DW5Msc